A Phase 3, Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection As Compared To Saline Placebo Injection In The Treatment Of Plantar Fasciitis
Phase of Trial: Phase III
Latest Information Update: 11 Nov 2019
Price : $35 *
At a glance
- Drugs DHACM (Primary)
- Indications Plantar fasciitis
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors MiMedx
- 25 Sep 2019 Planned number of patients changed from 164 to 276.
- 25 Sep 2019 Planned End Date changed from 1 Oct 2019 to 1 Nov 2020.
- 25 Sep 2019 Planned primary completion date changed from 1 Oct 2019 to 1 Aug 2020.